GuiZhou SanLi Pharmaceutical Co.,Ltd
public_traded
GuiZhou SanLi Pharmaceutical Co.,Ltd is publicly traded on SHH under ticker 603439.SS.
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.